Biotaitan Molmed Co., Ltd. focused on developing rapid real-time quantitative PCR (rRT-PCR) platform for point-of-care testing (POCT). The platform is designed for molecular precision testing applications in healthcare facilities, ambulances, clinics, pharmacies and homes. At the latest trade show, Biotaitan launched AcesoBox, a portable POCT rRT-PCR device. The device uses a patented rapid thermal cycle system that integrates multi-channel optical detection, allowing users to process samples through simple extraction and obtain up to 15 target results within 5-10 minutes, demonstrating excellent market competitiveness.

The application of medical robots is becoming increasingly widespread, playing a crucial role in daily healthcare tasks. Take the seemingly simple task of urinary care as an example, which has traditionally been performed by healthcare professionals. However, with the onset of an aging society, the loads for medical cares but shortage of healthcare personnel has become an increasingly serious problem. In response to these challenges, research teams have been working continuously through discussions and clinical trials to improve the design of medical robots._x000D_
_x000D_
Our solution not only helps reduce the burden on healthcare workers but also improves the quality of medical services. In the future, we expect more types of medical robots to emerge, making significant contributions to human health and well-being._x000D_

Wine-Font Inc. is leading provider of cutting-edge medical devices, will showcase its latest range of diagnostic solutions at the upcoming Healthcare Expo Taiwan. The company is committed to empowering healthcare professionals with accurate and reliable tools for improved patient care. _x000D_
_x000D_
Key products on display include:_x000D_
* Roche cobas b 101 system: A comprehensive biochemistry analyzer for HbA1c, lipid profile, and CRP testing._x000D_
* Roche cobas h232 cardiac reader: A high-precision cardiac marker analyzer for rapid and accurate results._x000D_
* Urisys® 1100 urine analyzer: A reliable urine analyzer with connectivity to cobas POC IT solution._x000D_
* Radiometer ABL9 blood gas analyzer: A comprehensive blood gas analyzer for critical care settings. _x000D_
* Roche CoaguChek XS system: A portable coagulation monitoring system for patient self-testing.

Tandry recently showcased its latest advancements at the 86th Annual Meeting of the Taiwan Orthopedic Association (TOA), including its variable-angle locking plate system, underscoring Tandry’s commitment to innovation and quality in orthopedics. The event highlighted Tandry’s international expansion efforts and its collaboration with National Yang Ming Chiao Tung University in developing cutting-edge femoral repair technology, further establishing Tandry as a "hidden champion" of Taiwanese innovation.

BriteMED's upcoming wireless 12-lead portable ECG builds upon the first generation's Windows-based portable ECG transmission, offering groundbreaking solutions for telemedicine, rural healthcare, and home care. This next-generation device features Bluetooth 5.0 technology for enhanced cross-platform compatibility, allowing real-time ECG waveform transmission on Windows, iOS, and Android devices. It also provides clinically validated diagnostic support features.
The device utilizes a non-invasive physiological signal acquisition method, making it easy to monitor patients' heart activity, and it can transmit data electronically, facilitating further tracking and diagnosis. In emergencies, it is equipped with defibrillator protection and pacemaker detection functions to ensure safe usage. BriteMED’s wireless 12-lead portable ECG effectively improves the efficiency of cardiovascular disease diagnosis and management.
Amid the rising global prevalence of cardiovascular/heart diseases, BriteMED provides practical solutions in telemedicine and smart healthcare to address current challenges in diagnosing and managing heart conditions, especially in settings like remote medical consultations, rural healthcare, home care, and mobile clinics, both inside and outside traditional hospital environments.

Applied BioCode, multiplex diagnostics company, exhibits at 2024 Taiwan Healthcare+ Expo, showcasing comprehensive and flexible multiplex diagnostics solution, strides forward to gain global diagnostics market.

Applied BioCode’s solution has shown international traction. With premarket clearance FDA 510k and TFDA registrations for Gastrointestinal Pathogen Panel and Respiratory Pathogen Panel in hand, Applied BioCode rapidly increases install bases of its automated molecular system BioCode MDx3000 in North America recently. Based on this very system, Applied BioCode continues to develop Cov-Flu-Plus, Multiplex Fungal Panel, and STI panel plus resistance markers. Applied BioCode aims to boost presence and utility among the top 600 largest reference labs and medical centers in the US, becoming high throughput multiplex diagnostics leader, and collaborates with Taiwan’s high quality healthcare systems.

Taiwan Healthcare Plus expo will kick off on Dec. 5th in Nangang Exhibition Center I, and Applied BioCode has booth on 4th floor M403.

Dr. Linus Pauling, two-time Nobel Prize winner, once said, “The root cause of most human diseases lies in the lack of trace minerals.” This statement has had a profound impact on future generations, highlighting the importance of complete and balanced nutrition for human health. Inspired by this principle, Total Swiss is committed to providing comprehensive and balanced nutrition to promote cellular health. Following the philosophy that "when cells are healthy, people are healthy," Total Swiss actively strives to help people regain health and stay free from disease.

Since 2022, Total Swiss has partnered with DeYen Pharmaceutical, securing exclusive global sales rights for *Hepanamin Capsule*, an indicated therapy for chronic liver disease. In just one year, Total Swiss quickly expanded to over 40 *Hepanamin* pharmacies. This year, Total Swiss has further joined forces with DyterGene Technology to officially enter the field of precision medicine, becoming a health industry group that integrates precision medicine, PIC/S GMP pharmaceutical manufacturing, and nutrition and health products. Total Swiss is dedicated to offering comprehensive and superior health solutions for people both domestically and internationally.

An interdisciplinary team from the Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKUMed) has developed an innovative artificial intelligence (AI) software system that can turn an ordinary mobile phone into a medical-grade stethoscope, allowing anyone to use a smartphone to detect heart disease symptoms at their fingertips, and subsequently seek immediate medical attention, without the need for other specialised devices. This patented AI technology enables the detection of valvular heart disease, with an estimated accuracy of 81% – a level comparable to a doctor’s assessment using a stethoscope. This invention promotes early detection of valvular heart disease, personalised health management, heart disease screening, the use of telemedicine, and remote disease monitoring.

At the forefront of future healthcare, filled with challenges, VitalSigns Corp introduces the best wireless, precise, real-time, continuous, analytical, and regulatory-compliant solution, addressing the dual challenge of improving healthcare workers' environments and enabling real-time monitoring of patients' vital signs. Through the wearable multifunctional physiological data collection device VSH101 and the physiological information gateway VSG101, we have launched the revolutionary ECG + Vitals™ service. This service provides 24-hour continuous real-time ECG monitoring and instant interpretation, even in ICU settings, bringing comprehensive monitoring to every corner, assisting dedicated healthcare workers in safeguarding every life!

"Sense Innovation" works exclusively with the eye-tracking device developer Tobii Dynavox as a local expert in Taiwan and is also capable of developing gaze-interaction software. Since 2015, Sense Innovation has been developing various types of eye-tracking softwares that encourage independence for people with disabilities to communicate and work on a computer via eye control. This year, Sense Innovation will showcase a new generation of eye gaze-enabled device, the "TD I-Series," at the Health Care Expo.

TD I-Series is a Windows-based all-in-one device that can be controlled completely with the eyes. It comes in 16-inch and 13-inch screen sizes and can be operable with either the eye control or the touch, or with a mouse or special switches. It includes the built-in eye-control AAC communication software known as TD Snap, enabling therapists to assist patients in eye-tracking speech therapy and making it easier for healthcare providers and aphasic patients to communicate.

We will showcase various mounts paired with the eye-control device on-site, offering a one-stop solution. Additionally, it will be the first public display of "The Eyeland"—an eye-tracking visual perception assessment software—and "The Sense AEye", an eye-tracking E-learning platform complete with teaching materials, tools and resources. Visitors are welcome to come by the booth (J1030) to learn more and try out the products.

This product proposes a personal health guardian: heart health management system and platform with electrocardiogram (ECG) analysis and cardiac disease detection. The system includes front-end IoT-based hardware, a user interface on the smart device’s application (APP), a cloud database, and an AI platform for cardiac disease detection. The front-end IoT-based hardware, a wearable ECG patch with an analog front-end circuit and a Bluetooth module, can detect ECG signals. The APP on smart devices can not only display users’ real-time ECG signals but also label unusual signals instantly and reach real-time disease detection. These ECG signals will be uploaded to the cloud database. The cloud database is used to store each user’s ECG signals, which forms a big-data database for AI algorithms to detect cardiac disease. The classification categories of this model are based on the Advancement of Medical Instrumentation (AAMI) standard to fit the FDA/TFDA regulation and the average accuracy is more than 98.32%. The ECG dataset applied in this product is collected from patients in Tainan Hospital, Ministry of Health and Welfare. Moreover, signal verification was also performed by a cardiologist. The main advantages of this system are real-time monitoring, convenience for wear, and ease of use. This patch has been approved by TFDA (ID: 008050)( https://lmspiq.fda.gov.tw/web/MDPIQ/MDPIQ1000Result?licBaseId=1B7F2D5D-CDCC-4532-84BE-DCF74E65E687 ) with QMS2183. The service iOS APP (https://apps.apple.com/tw/app/yuguard/id6469807344 ) also provides anytime and anywhere arrhythmia monitoring. These can achieve home heart disease care, assist clinics in diagnosing heart diseases, and provide remote heart disease consultations, solving current medical dilemmas and achieving the goal of public health.

To foster the growth of the global exosome industry, BIONET Corp. actively invites international partners to explore various collaboration opportunities and create exosome business prospects together.
BIONET has focused in four areas: "Exosome", "Cell Therapy", "Precision Medicine/Genetic Testing" and "Scientific Informatics".
With 25 years of experience in regenerative medicine, BIONET's exosomes are produced using exclusive nano-purification technology.
Through BIONET Corp.'s exclusive Meta Exosome comprehensive solution, we offer a wide range of exosome R&D and manufacturing services to various industries both domestically and internationally. We are dedicated to our global exosome R&D center and world-class manufacturing hub, providing our partners with high-quality, high-standard, and reliable exosomes at the scale of mass production.

Gene Target, a leading brand in precision health, unveiled its three core technologies—Super Chips, Super Lab, and Super AI—at the latest exhibition, setting a new standard in the biotech industry.

The Super Chips, powered by a database of 5 million Chinese genomes, combined with the fully automated Super Lab, can test over 32 samples in just 3 hours. This system offers high efficiency, low cost, and exceptional precision—delivering the performance of a $3 million lab for just $200,000. Super AI adds an interactive layer, serving as both an educational platform and a market insight tool.

These three innovations create a seamless precision health loop: Super Chips for accurate genetic analysis, Super Lab for enhanced testing efficiency, and Super AI for presenting complex medical technology in an intuitive, interactive way. Gene Target aims to serve 5 million customers worldwide within five years, creating a trillion-dollar business opportunity.

Taipei, August 26, 2024** — Pioneer Biotech Co., Ltd. today announced that it has secured the exclusive rights from U.S.-based Bio Pleo to distribute its newly developed natural health product, ERAD Plus® tablets, across Asia. The company received Taiwan’s Ministry of Health and Welfare's import approval for the product in June of this year. ERAD Plus® is designed to improve the health of pancreatic beta cells in diabetic patients by enhancing the physiological process known as Endoplasmic Reticulum-Associated Degradation (ERAD). This process helps correct misfolded proinsulin, preventing the accumulation of errors that lead to endoplasmic reticulum stress. ERAD Plus® provides a unique opportunity for protecting and regenerating pancreatic beta cells, slowing the progression of diabetes and working synergistically with existing glucose-lowering medications.

Sandalphon International Inc. and frequency technology experts have jointly launched sleep-aid products to improve sleep quality. Frequency technology reduces disturbances in the sleep environment and promotes the body's natural repair through frequency resonance. It also complements traditional apnea treatments and provides apnea patients with a more comfortable choice.
Hospital caregivers pointed out that apnea can cause a variety of health problems, and traditional treatments often require a long time to adapt. In order to seek a more effective solution that personally used the Sleepbank product in combination and found that it can significantly reduce the discomfort of wearing shallow sleep and the difficulty in returning to sleep after waking up, improving the overall sleep quality.

The Charder MA801 utilizes Bioelectrical Impedance Analysis to quickly and safely measure Body Composition Analysis. In addition to full-body and segmental muscle and fat, clinically validated results include cellular health, body water balance, and other advanced indicators of health status.

Visitors to Charder’s booth can receive free scans between 10:00-12:00 and 14:00-16:00 during the exhibition.

GiMialign: The Latest Medical Technology! The Master of Ergonomics! With multiple 20-year invention patents in 43 countries, GiMialign perfectly combines medicine, biomechanics, and technology. Any improper body posture is corrected instantly with GiMialign AI 3D Kinetic Socks.

GiMialign AI 3D Kinetic Socks actively lift the arch, drive muscle contractions, increase kinetic energy, promote circulation, push back the displaced bones of the inner arch, and adjust posture misalignment. Their performance surpasses orthopedic insoles (which only provide passive support when standing still, have no active lifting force, and cannot push back the displaced bones of the inner arch).

Features:

1、Flat feet, leg length discrepancy, and pelvic tilt—corrected in 1 second!
(Instant verification)
2、Performance surpasses orthopedic insoles
3、Long standing, hiking, and running—no back pain or leg fatigue
4、Weight training without improper posture
5、Patented 3D bands counteract incorrect biomechanics
6、The world's only tool for perfect golden arch shaping